Find out how a new partnership between Manulife and Loblaw is changing access to prescription drugs in Canada!
The recent Manulife-Loblaw deal has stirred controversy and raised questions about the ties between insurance companies and pharmacies in Canada. Manulife's decision to limit coverage of specialty prescription drugs to only apply at Loblaw-owned pharmacies, such as Shoppers Drug Mart, has left many Canadians concerned about restricted access to crucial medications.
This new arrangement affects around 260 medications, impacting plan holders who may now have to switch pharmacies to continue receiving coverage for their essential drugs. Alberta advocates have expressed worry over the implications of this exclusive partnership on patients' access and choices in healthcare.
The collaboration between Manulife and Loblaw, seen as
Manulife says its coverage of certain specialty prescription drugs will only apply at Loblaw-owned pharmacies, raising questions over the relationship ...
The new arrangement, details of which were shared with plan holders earlier this month, affects around 260 medications under the insurance company's ...
This comes after Manulife announced its coverage of certain prescription drugs will only apply at Loblaw Pharmacies, such as Shoppers Drug Mart. The move ...
Insurance company Manulife has announced big changes in how it covers certain prescription drugs, with roughly 260 medications now only available for ...
Canadians who have insurance with Manulife may need to swap pharmacies in order for their medication to be covered. According to details obtained by The ...
Manulife and Loblaw are facing backlash after the companies announced that they are teaming up to provide specialty drug care.
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced ...
The statement from the insurer suggests Loblaw Cos. Ltd. pharmacies will be eligible for its coverage of specific prescription medications.
Some pharmacare policy experts are raising concerns about competition and patient access to much-needed medication after Manulife Financial Corp. announced ...